Table 4.
Angiogenesis and cell adhesion-related genes
| Probe Set ID | Gene Symbol | Fold Change (GW vs. C) | P Value | FDR | Gene Name |
|---|---|---|---|---|---|
| Bt.27997.1.S1_at | HMMR | 2.24 | 0.000 | 0.051 | hyaluronan-mediated motility receptor (RHAMM) |
| Bt.6125.2.S1_at | JAG1 | 2.20 | 0.001 | 0.128 | jagged 1 (Alagille syndrome) |
| Bt.29836.1.S1_at | FLK-1 | 2.04 | 0.008 | 0.214 | vascular endothelial growth factor receptor 2 |
| Bt.20111.1.S1_at | TNFRSF12A | 1.88 | 0.003 | 0.196 | tumor necrosis factor receptor superfamily, member 12A |
| Bt.22840.1.S1_a_at | CD46 | 1.84 | 0.000 | 0.084 | CD46 molecule, complement regulatory protein |
| Bt.11873.1.A1_at | SSX2IP | 1.81 | 0.007 | 0.214 | synovial sarcoma, X breakpoint 2 interacting protein |
| Bt.4353.1.S1_at | EPAS1 | 1.77 | 0.000 | 0.110 | endothelial PAS domain protein1 |
| Bt.5129.2.A1_at | NNAT | 1.76 | 0.040 | 0.221 | neuronatin |
| Bt.4834.1.S1_at | FGF2 | 1.68 | 0.010 | 0.214 | fibroblast growth factor 2 (basic) (associated with hyaluronan) |
| Bt.27.1.S1_at | YWHAG | 1.60 | 0.009 | 0.214 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
| Bt.28459.1.S1_at | BMP4 | 1.59 | 0.046 | 0.226 | bone morphogenetic protein 4 |
| Bt.25926.1.A1_at | PDE3B | 1.57 | 0.002 | 0.190 | phosphodiesterase 3B, cGMP-inhibited |
| Bt.4781.1.S1_at | ADAM10 | 1.57 | 0.005 | 0.214 | ADAM metallopeptidase domain 10 |
| Bt.25447.1.A1_at | EPHA7 | 1.55 | 0.015 | 0.214 | EPH receptor A7 |
| Bt.28750.1.S1_at | IL13RA1 | 1.53 | 0.003 | 0.250 | interleukin-13 receptor, α-1 |
| Bt.5395.1.S1_a_at | VCAN | 1.47 | 0.000 | 0.118 | versican |
| Bt.8131.1.S1_at | ALCAM | 1.40 | 0.045 | 0.225 | activated leukocyte cell adhesion molecule |
The significantly upregulated angiogenesis and cell adhesion-related genes are listed. For each gene, the Affymetrix probe set ID, the gene symbol, fold change, P value, the FDR, and the gene name are given.